Table 4.

Multivariate analysis of EP300 SNP rs20551 on survival in 226 DLBCL patients

Variable	Hazard ratio	95% CI	p
GA/AA	2.956	1.315–6.645	0.009
B symptom	0.502	0.271–0.928	0.028
β2-MG	2.239	1.201–4.175	0.011
IPI	2.435	1.362–4.354	0.003
Clinical response	0.06	0.030–0.120	<0.001